Thomas Lahiri - Concepedia

Author

Thomas Lahiri

Boston Children's Hospital ORCID

Also Known As

Laurie Chassereau, Michael Konstan, T K Lahiri, T. Lahiri, Thomas Lahiri

Publications

Citations

H-Index

Concepts

All Affiliations

Boston Children's Hospital Harvard University University of Vermont University of Pennsylvania University of Colorado Denver

About

Thomas Lahiri is an author at Boston Children's Hospital specializing in medicine, pulmonary fibrosis, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	599
2	Child Development	1	1	12
3	Gastroenterology	1	1	10
4	Hepatology	1	1	10
5	Orthopaedics	1	1	73

Thomas Lahiri

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial Félix Ratjen, Christopher Hug, Gautham Marigowda, The Lancet Respiratory Medicine Pulmonary FibrosisMedicinePlacebo-controlled Phase 3	2017	291
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell, The Lancet Respiratory Medicine MedicineHypertonic SalineDornase AlfaPulmonary Fibrosis	2022	116
Changing Epidemiology of Life-Threatening Upper Airway Infections: The Reemergence of Bacterial Tracheitis Amelia Hopkins, Thomas Lahiri, Richard Salerno, PEDIATRICS	2006	89
Endoscopic sinus surgery in cystic fibrosis: do patients benefit from surgery? Kristina W. Rosbe, Dwight T. Jones, Reza Rahbar, International Journal of Pediatric Otorhinolaryngology Endoscopic SurgeryEndoscopic Sinus SurgerySurgeryInterventional EndoscopyMedicine	2001	73
Baseline Characteristics and Factors Associated With Nutritional and Pulmonary Status at Enrollment in the Cystic Fibrosis EPIC Observational Cohort Margaret Rosenfeld, Julia Emerson, Sharon McNamara, Pediatric Pulmonology	2010	60
Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function Wayne J. Morgan, Donald R. VanDevanter, David J. Pasta, The Journal of Pediatrics Advanced Lung DiseaseForced Expiratory VolumePulmonary PhysiologyGreater LossPulmonary Fibrosis	2015	59
Selected Contribution: Synergism between TNF-α and IL-1β in airway smooth muscle cells: implications for β-adrenergic responsiveness Paul E. Moore, Thomas Lahiri, Johanne D. Laporte, Journal of Applied Physiology	2001	57
p38 MAP kinase regulates IL-1β responses in cultured airway smooth muscle cells Johanne D. Laporte, Paul E. Moore, Thomas Lahiri, American Journal of Physiology-Lung Cellular and Molecular Physiology	2000	54
A Breath Biofeedback Computer Game for Children With Cystic Fibrosis Peter M. Bingham, Jason H. T. Bates, John Thompson-Figueroa, Clinical Pediatrics	2010	46
Interleukin-6 family cytokines: signaling and effects in human airway smooth muscle cells Thomas Lahiri, Johanne D. Laporte, Paul Moore, American Journal of Physiology-Lung Cellular and Molecular Physiology	2001	39

Page 1